COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
GD Barnes, A Burnett, A Allen, M Blumenstein… - Journal of thrombosis …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …
SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial
AK Sista, JM Horowitz, VF Tapson, M Rosenberg… - Cardiovascular …, 2021 - jacc.org
Objectives This study sought to prospectively evaluate the safety and efficacy of the Indigo
aspiration system in submassive acute pulmonary embolism (PE). Background PE treatment …
aspiration system in submassive acute pulmonary embolism (PE). Background PE treatment …
A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study
T Tu, C Toma, VF Tapson, C Adams, WA Jaber… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: The aim of this study was to evaluate the safety and effectiveness of
percutaneous mechanical thrombectomy using the FlowTriever System (Inari Medical, Irvine …
percutaneous mechanical thrombectomy using the FlowTriever System (Inari Medical, Irvine …
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
Therapeutic strategies for thrombosis: new targets and approaches
N Mackman, W Bergmeier, GA Stouffer… - Nature reviews Drug …, 2020 - nature.com
Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …